Monday, April 29, 2013

What's next for the FDA with regulating iPharmacies?

(by Patrick Harris, Business & Technical Project and Product Manager for the Digital Age)

About six weeks ago, the FDA set precedence when they took action against a dietary supplement maker that used Facebook to “Like” an unapproved claim regarding one of its products.  In this Warning Letter, FDA cited a multitude of serious violations against the marketer of a drug product called Poly-MVA. The company had sold its product through the use of testimonials that were not substantiated by good science, according to FDA.

Just one week prior to this, the FDA issued a warning letter to a drug maker over that company’s use of a search bar on its web site. The FDA faulted the firm for improperly linking disease queries directly with drugs that the company marketed.

The FDA has historically been reluctant to publish clear guidance when it comes to how it regulates promotion.  With the speed of the web, must they adapt their traditional governing principals?  If they have plans to regulate Internet Pharmacies starting with promotion regulations, what’s next?

Going back a few months to October 2012, we noted a new FDA campaign - “BeSafeRx - Know your Online Pharmacy".  The FDA BeSafeRx is a national campaign to raise awareness of the dangers of buying prescription medicines from fake online pharmacies. This campaign provides the resources to help consumers: (1) Know the Risks - Learn the Dangers of Buying from an Online Pharmacy (2) Know the Signs - Identify the Signs of a Fake Online Pharmacy (3) Know your Online Pharmacy - Find a Safe Online Pharmacy.  Was this the first hint of regulation by establishing a consumer baseline of sorts? 

There is no question that the FDA is seeking to keep up with the demands and fast-paceness of the digital age with the goal of protecting consumers.  However, the warning letters are just the start.  Also, look for external guidance for third-party organizations such as the Alliance for Safe Online Pharmacies (ASOP).  

In my option, Online Pharmacies should take proactive action in protecting themselves.  This includes keeping extremely current with forthcoming guidance from the FDA.  There will probably be more of these types of warning letters in the near future.  Online pharmacies should operate within this guidance and have the Standard Operating Procedures in place and documented.  In terms of Social Media, this means creating more private networks that are less than ‘socialable’ (just to be safe).  In efforts to offset this regulation by the FDA, online Pharmacies should also familiarize themselves with the manufacturers promotion of such items as their advertisements are heavily regulated.  Internet Pharmacies can also take note from the Pharmaceutical, Clinical and related drug development industries.  These very tight regulations will likely trickle down in various forms, particularly the regulations related to consumer promotion.

For more information about PharmaSys, please visit our website at www.pharma-sys.com.

No comments:

Post a Comment